Sildenafil, 2004 Coll. Milestones in Drug Therapy
Coordonnateur : Dunzendorfer Udo
Sildenafil, for the treatment of erectile dysfunction, is one of the first products that has made its way successfully from basic NO (nitrous oxide) research, to clinical routine therapy. Sidenafil, part of the Milestones in Drug Therapy series, presents the major breakthroughs in the field of NO physiology and pharmacology that led to the development of the drug, as well as clinical applications in one source guide.
Written by leading experts in the field, each chapter covers aspects of clinical use and experience, pharmacokinetics, pharmacodynamics, biochemistry, and cultural science.
Topical volume about a landmark discovery
Written by leading experts in the field
Detailed and up-to-date knowledge base
Includes supplementary material: sn.pub/extras
Date de parution : 10-2012
Ouvrage de 202 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 210,99 €
Ajouter au panierDate de parution : 10-2004
Ouvrage de 202 p.
15.5x23.5 cm
Thèmes de Sildenafil :
Mots-clés :
biochemistry; cancer; chemistry; development; drug; endothelium; erectile dysfunction; kinetics; pharmacodynamics; pharmacokinetics; pharmacology; physiology; research; resistance; tissue